The Number 1 Small-Cap Biotech Investors are Missing Out On Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a small-cap biotech company that investors should consider. Source: BioSpace You Might Also Like Bay Area Versartis's Stock Collapses as Growth Hormone Drug Flunks Phase III Test September 21, 2017 Biocept, Inc. Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells January 18, 2017 SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test September 11, 2017
Biocept, Inc. Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells January 18, 2017
